Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 779

1.
2.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
[PubMed - indexed for MEDLINE]
3.

Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.

Reyes Calzada S, Martínez Tomas R, Cremades Romero MJ, Martínez Moragón E, Soler Cataluña JJ, Menéndez Villanueva R.

Respir Med. 2007 Sep;101(9):1909-15. Epub 2007 Jul 12.

PMID:
17628462
[PubMed - indexed for MEDLINE]
Free Article
4.

Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.

Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menéndez R, Lopardo G, Torres A, Rossi P, Ramirez JA; Community-Acquired Pneumonia Organization (CAPO) Investigators.

Arch Intern Med. 2009 Sep 14;169(16):1515-24. doi: 10.1001/archinternmed.2009.265.

PMID:
19752410
[PubMed - indexed for MEDLINE]
5.

Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.

Frei CR, Restrepo MI, Mortensen EM, Burgess DS.

Am J Med. 2006 Oct;119(10):865-71.

PMID:
17000218
[PubMed - indexed for MEDLINE]
6.

Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.

McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN.

Arch Intern Med. 2009 Sep 14;169(16):1525-31. doi: 10.1001/archinternmed.2009.259.

PMID:
19752411
[PubMed - indexed for MEDLINE]
7.

Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.

Gleason PP, Kapoor WN, Stone RA, Lave JR, Obrosky DS, Schulz R, Singer DE, Coley CM, Marrie TJ, Fine MJ.

JAMA. 1997 Jul 2;278(1):32-9.

PMID:
9207335
[PubMed - indexed for MEDLINE]
8.
9.

Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.

Mortensen EM, Restrepo M, Anzueto A, Pugh J.

Am J Med. 2004 Nov 15;117(10):726-31.

PMID:
15541321
[PubMed - indexed for MEDLINE]
10.

Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals.

Davydov L, Ebert SC, Restino M, Gardner M, Bedenkop G, Uchida KM, Bertino JS Jr.

Diagn Microbiol Infect Dis. 2006 Apr;54(4):267-75. Epub 2006 Feb 8.

PMID:
16466891
[PubMed - indexed for MEDLINE]
11.

Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort.

Wu JH, Howard DH, McGowan JE Jr, Turpin RS, Henry Hu X.

Clin Ther. 2006 Sep;28(9):1451-61.

PMID:
17062317
[PubMed - indexed for MEDLINE]
12.

[Appropriate use of antibiotics in hospitals. Investigating clinical practices in management of community-acquired pneumonia].

Navas D, Caillon J, Potel G.

Presse Med. 2005 Dec 17;34(22 Pt 1):1687-95. French.

PMID:
16374388
[PubMed - indexed for MEDLINE]
13.

Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.

Marras TK, Nopmaneejumruslers C, Chan CK.

Am J Med. 2004 Mar 15;116(6):385-93.

PMID:
15006587
[PubMed - indexed for MEDLINE]
14.

Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG.

Arch Intern Med. 2004 Mar 22;164(6):637-44.

PMID:
15037492
[PubMed - indexed for MEDLINE]
15.

Influence of deviation from guidelines on the outcome of community-acquired pneumonia.

Menéndez R, Ferrando D, Vallés JM, Vallterra J.

Chest. 2002 Aug;122(2):612-7.

PMID:
12171840
[PubMed - indexed for MEDLINE]
16.

Empiric management of community-acquired pneumonia in Australian emergency departments.

Maxwell DJ, McIntosh KA, Pulver LK, Easton KL.

Med J Aust. 2005 Nov 21;183(10):520-4.

PMID:
16296965
[PubMed - indexed for MEDLINE]
17.

Improved clinical outcomes with utilization of a community-acquired pneumonia guideline.

Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D.

Chest. 2006 Sep;130(3):794-9.

PMID:
16963677
[PubMed - indexed for MEDLINE]
18.

Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.

Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, Bilbao A.

Clin Infect Dis. 2004 Oct 1;39(7):955-63. Epub 2004 Sep 8.

PMID:
15472846
[PubMed - indexed for MEDLINE]
Free Article
19.

[Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].

Díaz A, Kuzmanic G, Platzer L, Sanfuentes F, Espinoza MA, Saldías F.

Rev Med Chil. 2003 Aug;131(8):847-56. Spanish.

PMID:
14558238
[PubMed - indexed for MEDLINE]
20.

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.

Frei CR, Jaso TC, Mortensen EM, Restrepo MI, Raut MK, Oramasionwu CU, Ruiz AD, Makos BR, Ruiz JL, Attridge RT, Mody SH, Fisher A, Schein JR.

Curr Med Res Opin. 2009 Apr;25(4):859-68. doi: 10.1185/03007990902779749 .

PMID:
19231913
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk